News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

NeoGraft Increases Its Market Lead With Acquisition Of Hair Transplant Device Manufacturer Medicamat



11/15/2016 10:26:23 AM

  Life Sciences Jobs  
  • Newest Jobs - Last 24 Hours
  • California Jobs
  • Massachusetts Jobs
  • New Jersey Jobs
  • Maryland Jobs
  • Washington Jobs
  View More Jobs

LEWISVILLE, Texas, Nov. 15, 2016 /PRNewswire/ --

  • Acquisition makes NeoGraft® the largest supplier of hair transplant devices in the world.
  • Acquisition accelerates the NeoGraft® research and development pipeline.
  • Acquisition allows NeoGraft® to unify its brand worldwide.
  • Acquisition demonstrates NeoGraft® Solutions commitment to a continuum of care.
NeoGraft(R) is the highest rated hair transplant surgery on RealSelf.com NeoGraft(R) is the first FDA-cleared follicular unit harvesting and implantation system that extracts individual hair follicles. Compared to the traditional strip method, a NeoGraft(R) procedure is minimally invasive, requires significantly less recovery time, and has 20 years of clinically proven results. NeoGraft(R) Solution's vision is to be the world leader in hair restoration, supplying the latest innovations in technology, education, and patient care.

Today, NeoGraft® Solutions announced its acquisition of the French company Medicamat®. With this addition, NeoGraft® is now poised to rapidly expand their position as the worldwide leader of the $2.5-billion hair restoration market. As the market leader of follicular unit extraction devices in the United States of America, this move furthers NeoGraft's® mission to become the most trusted global authority on minimally invasive hair restoration.

"Medicamat® has been a dedicated partner for almost a decade and their reputation is respected across the globe," said Glenn Normoyle, President of NeoGraft. "Acquiring Medicamat® stabilizes our core offering, while accelerating our research and development pipeline."

The acquisition brings all of Medicamat's® assets under NeoGraft® Solutions' brand umbrella, and follows a series of moves by NeoGraft® to distinguish itself as more than a traditional medical device company.

"Acquiring Medicamat® deepens NeoGraft's commitment to patient safety and physician education programs. As we continue to broaden our offering away from a single device, we now provide a complete continuum of care for hair restoration, both surgically and non-surgically. We are dedicated to making sure our patients have the best options and make the most informed choices for treating their hair loss," said Jack Fisher, MD, NeoGraft Chief Medical Officer, Board Certified Plastic Surgeon, and former President of The American Society for Aesthetic Plastic Surgery.

About NeoGraft:

NeoGraft® is the first FDA-cleared follicular unit harvesting and implantation system that extracts individual hair follicles. Compared to the traditional strip method, a NeoGraft® procedure is minimally invasive, requires significantly less recovery time, and has 20 years of clinically proven results. NeoGraft® Solution's vision is to be the world leader in hair restoration, supplying the latest innovations in technology, education, and patient care.

CONTACT:

Contact Person:Chad Brophy

Company Name: NeoGraft® Solutions

Voice Phone Number: (844) 343-4247

FAX Number: (972) 767-4030

Email Address:chad@neograft.com

Website URL:www.neograft.com

NeoGraft_Logo

 

Photo - http://photos.prnewswire.com/prnh/20161114/439045
Logo - http://photos.prnewswire.com/prnh/20161114/439044LOGO

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/neograft-increases-its-market-lead-with-acquisition-of-hair-transplant-device-manufacturer-medicamat-300362533.html

SOURCE NeoGraft


Read at BioSpace.com


comments powered by Disqus
NeoGraft
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES